Home/Talus Bioscience/Gaelle Mercenne, Ph.D.

GM

Gaelle Mercenne, Ph.D.

Head of Biology

Talus Bioscience

Therapeutic Areas

Oncology Immunology Rare Disease Cardiometabolic

Talus Bioscience Pipeline

Drug	Indication	Phase
TBXT	Chordoma, Lung Cancer	Pre-clinical
NONO/AR–V7	Castration–Resistant Prostate Cancer	Pre-clinical
Undisclosed Transcription Factor	Solid Tumor	Discovery

Leadership Team at Talus Bioscience

Alex Federation, Ph.D.

Chief Executive Officer & Co-Founder

Lindsay Pino, Ph.D.

Chief Technology Officer & Co-Founder

Christopher Joyce, MBA

VP of Business Development

View full Talus Bioscience profile